11β-hydroxysteroid dehydrogenase type 1 is expressed in human sebaceous glands and regulates glucocorticoid-induced lipid synthesis and toll-like receptor 2 expression in SZ95 sebocytes

British Journal of Dermatology

Volumn 168, Issue 1, 2013, Pages 47-55

  Lee, S E ^a   Kim, J M ^b   Jeong, M K ^b   Zouboulis, C C ^c   Lee, Seung Hun ^b  

^a CHA University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c DESSAU MEDICAL CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; CYTOKINE; DEXAMETHASONE; PF 915275; SMALL INTERFERING RNA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TOLL LIKE RECEPTOR 2;

ACNE VULGARIS; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIPOGENESIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEBACEOUS GLAND; UPREGULATION; VOLUNTEER;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ACNE VULGARIS; AMINOPYRIDINES; CELLS, CULTURED; DEXAMETHASONE; DUAL SPECIFICITY PHOSPHATASE 1; ENZYME INHIBITORS; GLUCOCORTICOIDS; HUMANS; INDOLES; LIPIDS; RNA, SMALL INTERFERING; SEBACEOUS GLANDS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; SULFONAMIDES; TOLL-LIKE RECEPTOR 2;

EID: 84872842911     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12009     Document Type: Article

References (33)

1. Chiu A, Chon SY, Kimball AB,. The response of skin disease to stress: changes in the severity of acne vulgaris as affected by examination stress. Arch Dermatol 2003; 139: 897-900.
2. Fung MA, Berger TG,. A prospective study of acute-onset steroid acne associated with administration of intravenous corticosteroids. Dermatology 2000; 200: 43-4.
3. Plewig G, Kligman AM,. Induction of acne by topical steroids. Arch Dermatol Forsch 1973; 247: 29-52.
4. Bass D, Zouboulis CC,. Behandlung der Acne fulminans mit Isotretinoin und Prednisolon. Z Hautkr 2001; 76: 473.
5. Böhm M, Luger TA,. The role of melanocortins in skin homeostasis. Horm Res 2000; 54: 287-93.
6. Ganceviciene R, Böhm M, Fimmel S, et al. The role of neuropeptides in the multifactorial pathogenesis of acne vulgaris. Dermatoendocrinol 2009; 1: 170-6.
7. Slominski A, Wortsman J, Luger T, et al. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 2000; 80: 979-1020.
8. Shibata M, Katsuyama M, Onodera T, et al. Glucocorticoids enhance Toll-like receptor 2 expression in human keratinocytes stimulated with Propionibacterium acnes or proinflammatory cytokines. J Invest Dermatol 2009; 129: 375-82.
9. Hewitt KN, Walker EA, Stewart PM,. Minireview: hexose-6-phosphate dehydrogenase and redox control of 11beta-hydroxysteroid dehydrogenase type 1 activity. Endocrinology 2005; 146: 2539-43.
10. Seckl JR,. 11beta-hydroxysteroid dehydrogenases: changing glucocorticoid action. Curr Opin Pharmacol 2004; 4: 597-602.
11. Tomlinson JW, Walker EA, Bujalska IJ, et al. 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 2004; 25: 831-66.
12. Odermatt A, Atanasov AG, Balazs Z, et al. Why is 11beta-hydroxysteroid dehydrogenase type 1 facing the endoplasmic reticulum lumen? Physiological relevance of the membrane topology of 11beta-HSD1. Mol Cell Endocrinol 2006; 248: 15-23.
13. Baudrand R, Domínguez JM, Carvajal CA, et al. Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients. Metabolism 2011; 60: 1775-80.
14. Espíndola-Antunes D, Kater CE,. Adipose tissue expression of 11beta-hydroxysteroid dehydrogenase type 1 in Cushing's syndrome and in obesity. Arq Bras Endocrinol Metabol 2007; 51: 1397-403.
15. Tiganescu A, Walker EA, Hardy RS, et al. Localization, age- and site-dependent expression, and regulation of 11β-hydroxysteroid dehydrogenase type 1 in skin. J Invest Dermatol 2011; 131: 30-6.
16. Terao M, Murota H, Kimura A, et al. 11β-Hydroxysteroid dehydrogenase-1 is a novel regulator of skin homeostasis and a candidate target for promoting tissue repair. PLoS ONE 2011; 6: e25039.
17. Hauner H, Schmid P, Pfeiffer EF,. Glucocorticoids and insulin promote the differentiation of human adipocyte precursor cells into fat cells. J Clin Endocrinol Metab 1987; 64: 832-5.
18. Liu Y, Park F, Pietrusz JL, et al. Suppression of 11beta-hydroxysteroid dehydrogenase type 1 with RNA interference substantially attenuates 3T3-L1 adipogenesis. Physiol Genomics 2008; 32: 343-51.
19. Zouboulis CC, Xia L, Akamatsu H, et al. The human sebocyte culture model provides new insights into development and management of seborrhoea and acne. Dermatology 1998; 196: 21-31.
20. Masuzaki H, Flier JS,. Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)-a promising drug target for the treatment of metabolic syndrome. Curr Drug Targets Immune Endocr Metabol Disord 2003; 3: 255-62.
21. Georgel P, Crozat K, Lauth X, et al. A toll-like receptor 2-responsive lipid effector pathway protects mammals against skin infections with Gram-positive bacteria. Infect Immun 2005; 73: 4512-21.
22. Oeff MK, Seltmann H, Hiroi N, et al. Differential regulation of Toll-like receptor and CD14 pathways by retinoids and corticosteroids in human sebocytes. Dermatology 2006; 213: 266.
23. Nagy I, Pivarcsi A, Kis K, et al. Propionibacterium acnes and lipopolysaccharide induce the expression of antibacterial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes Infect 2006; 8: 2195-205.
24. Zouboulis CC, Seltmann H, Neitzel H, Orfanos CE,. Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95). J Invest Dermatol 1999; 113: 1011-20.
25. Deplewski D, Rosenfield RL,. Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation. Endocrinology 1999; 140: 4089-94.
26. Chen W, Liao CY, Hung CL, et al. Potent corticosteroids inhibit lipogenesis in sebaceous glands. Dermatology 2006; 213: 264-5.
27. Plewig G, Kligman AM,. Acne and Rosacea, 3rd edn. Berlin, Heidelberg, New York: Springer Verlag, 2000.
28. Shimano H, Yahagi N, Amemiya-Kudo M, et al. Sterol regulatory element-binding protein 1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J Biol Chem 1999; 274: 35832-9.
29. Chen W, Yang CC, Sheu HM, et al. Expression of peroxisome proliferator-activated receptor and CCAAT/enhancer binding protein transcription factors in cultured human sebocytes. J Invest Dermatol 2003; 121: 441-7.
30. Erhuma A, McMullen S, Langley-Evans SC, Bennett AJ,. Feeding pregnant rats a low-protein diet alters the hepatic expression of SREBP-1c in their offspring via a glucocorticoid related mechanism. Endocrine 2009; 36: 333-8.
31. Zouboulis CC,. The sebaceous glands. Hautarzt 2010; 61: 467-8.
32. Hammami MM, Siiteri PK,. Regulation of 11β-hydroxysteroid dehydrogenase activity in human skin fibroblasts: enzymatic modulation of glucocorticoid action. J Clin Endocrinol Metab 1991; 73: 326-34.
33. Sai S, Esteves CL, Kelly V, et al. Glucocorticoid regulation of the promoter of 11β hydroxysteroid dehydrogenase type 1 is indirect and requires CCAAT/enhancer-binding protein-β. Mol Endocrinol 2008; 22: 2049-60.